nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—Risedronate—osteoporosis	0.666	1	CbGbCtD
Trisalicylate-choline—Erythema multiforme—Etidronic acid—osteoporosis	0.00145	0.00437	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Calcium Acetate—osteoporosis	0.00144	0.00435	CcSEcCtD
Trisalicylate-choline—Pain—Calcium Acetate—osteoporosis	0.00142	0.00427	CcSEcCtD
Trisalicylate-choline—Constipation—Calcium Acetate—osteoporosis	0.00142	0.00427	CcSEcCtD
Trisalicylate-choline—Anorexia—Ergocalciferol—osteoporosis	0.00139	0.00421	CcSEcCtD
Trisalicylate-choline—Drowsiness—Calcitriol—osteoporosis	0.00138	0.00418	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Risedronate—osteoporosis	0.00138	0.00417	CcSEcCtD
Trisalicylate-choline—Sweating—Raloxifene—osteoporosis	0.00137	0.00413	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Calcium Acetate—osteoporosis	0.00136	0.00412	CcSEcCtD
Trisalicylate-choline—Sweating—Ibandronate—osteoporosis	0.00135	0.00409	CcSEcCtD
Trisalicylate-choline—Lethargy—Zoledronate—osteoporosis	0.00134	0.00404	CcSEcCtD
Trisalicylate-choline—Erythema—Etidronic acid—osteoporosis	0.00133	0.00402	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Estradiol—osteoporosis	0.00133	0.00402	CcSEcCtD
Trisalicylate-choline—Asthma—Risedronate—osteoporosis	0.00131	0.00395	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Ergocalciferol—osteoporosis	0.00127	0.00384	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Risedronate—osteoporosis	0.00125	0.00378	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Estropipate—osteoporosis	0.00125	0.00378	CcSEcCtD
Trisalicylate-choline—Pain—Ergocalciferol—osteoporosis	0.00125	0.00378	CcSEcCtD
Trisalicylate-choline—Constipation—Ergocalciferol—osteoporosis	0.00125	0.00378	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Alendronate—osteoporosis	0.00123	0.00372	CcSEcCtD
Trisalicylate-choline—Weight increased—Ethinyl Estradiol—osteoporosis	0.00122	0.00368	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Zoledronate—osteoporosis	0.0012	0.00362	CcSEcCtD
Trisalicylate-choline—Flushing—Raloxifene—osteoporosis	0.00119	0.00359	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Calcitriol—osteoporosis	0.00117	0.00355	CcSEcCtD
Trisalicylate-choline—Pruritus—Calcium Acetate—osteoporosis	0.00117	0.00354	CcSEcCtD
Trisalicylate-choline—Erythema—Estropipate—osteoporosis	0.00115	0.00348	CcSEcCtD
Trisalicylate-choline—Erythema—Alendronate—osteoporosis	0.00113	0.00343	CcSEcCtD
Trisalicylate-choline—Asthma—Zoledronate—osteoporosis	0.00113	0.00343	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Calcium Acetate—osteoporosis	0.00113	0.00342	CcSEcCtD
Trisalicylate-choline—Deafness—Estradiol—osteoporosis	0.00113	0.00341	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Alendronate—osteoporosis	0.00111	0.00336	CcSEcCtD
Trisalicylate-choline—Erythema—Ibandronate—osteoporosis	0.0011	0.00334	CcSEcCtD
Trisalicylate-choline—Confusional state—Etidronic acid—osteoporosis	0.0011	0.00331	CcSEcCtD
Trisalicylate-choline—Dizziness—Calcium Acetate—osteoporosis	0.00109	0.00331	CcSEcCtD
Trisalicylate-choline—Asthma—Conjugated Estrogens—osteoporosis	0.00109	0.0033	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Zoledronate—osteoporosis	0.00109	0.00328	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Ibandronate—osteoporosis	0.00108	0.00327	CcSEcCtD
Trisalicylate-choline—Erythema—Calcitriol—osteoporosis	0.00108	0.00327	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Calcitriol—osteoporosis	0.00106	0.0032	CcSEcCtD
Trisalicylate-choline—Vomiting—Calcium Acetate—osteoporosis	0.00105	0.00318	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.00105	0.00316	CcSEcCtD
Trisalicylate-choline—Weight increased—Zoledronate—osteoporosis	0.00103	0.00312	CcSEcCtD
Trisalicylate-choline—Lethargy—Estradiol—osteoporosis	0.00103	0.00312	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00101	0.00306	CcSEcCtD
Trisalicylate-choline—Weight increased—Conjugated Estrogens—osteoporosis	0.000994	0.003	CcSEcCtD
Trisalicylate-choline—Nausea—Calcium Acetate—osteoporosis	0.000983	0.00297	CcSEcCtD
Trisalicylate-choline—Tinnitus—Risedronate—osteoporosis	0.000975	0.00294	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Etidronic acid—osteoporosis	0.000956	0.00289	CcSEcCtD
Trisalicylate-choline—Oedema—Estropipate—osteoporosis	0.00094	0.00284	CcSEcCtD
Trisalicylate-choline—Constipation—Etidronic acid—osteoporosis	0.000929	0.00281	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Estradiol—osteoporosis	0.000924	0.00279	CcSEcCtD
Trisalicylate-choline—Flushing—Pamidronate—osteoporosis	0.000923	0.00279	CcSEcCtD
Trisalicylate-choline—Shock—Raloxifene—osteoporosis	0.000896	0.00271	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Etidronic acid—osteoporosis	0.000895	0.0027	CcSEcCtD
Trisalicylate-choline—Shock—Ibandronate—osteoporosis	0.000887	0.00268	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Raloxifene—osteoporosis	0.00088	0.00266	CcSEcCtD
Trisalicylate-choline—Asthma—Estradiol—osteoporosis	0.000874	0.00264	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Ibandronate—osteoporosis	0.000871	0.00263	CcSEcCtD
Trisalicylate-choline—Nausea—Ergocalciferol—osteoporosis	0.000868	0.00262	CcSEcCtD
Trisalicylate-choline—Erythema—Pamidronate—osteoporosis	0.000865	0.00261	CcSEcCtD
Trisalicylate-choline—Urticaria—Etidronic acid—osteoporosis	0.000863	0.00261	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Pamidronate—osteoporosis	0.000847	0.00256	CcSEcCtD
Trisalicylate-choline—Flushing—Zoledronate—osteoporosis	0.000843	0.00254	CcSEcCtD
Trisalicylate-choline—Anorexia—Calcitriol—osteoporosis	0.000841	0.00254	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Estradiol—osteoporosis	0.000838	0.00253	CcSEcCtD
Trisalicylate-choline—Somnolence—Estropipate—osteoporosis	0.000836	0.00252	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Estropipate—osteoporosis	0.000827	0.0025	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000827	0.0025	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Alendronate—osteoporosis	0.000815	0.00246	CcSEcCtD
Trisalicylate-choline—Constipation—Estropipate—osteoporosis	0.000804	0.00243	CcSEcCtD
Trisalicylate-choline—Pain—Estropipate—osteoporosis	0.000804	0.00243	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Raloxifene—osteoporosis	0.000802	0.00242	CcSEcCtD
Trisalicylate-choline—Weight increased—Estradiol—osteoporosis	0.000796	0.0024	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Ibandronate—osteoporosis	0.000793	0.0024	CcSEcCtD
Trisalicylate-choline—Pain—Alendronate—osteoporosis	0.000792	0.00239	CcSEcCtD
Trisalicylate-choline—Constipation—Alendronate—osteoporosis	0.000792	0.00239	CcSEcCtD
Trisalicylate-choline—Erythema—Zoledronate—osteoporosis	0.00079	0.00239	CcSEcCtD
Trisalicylate-choline—Somnolence—Calcitriol—osteoporosis	0.000784	0.00237	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Ibandronate—osteoporosis	0.000784	0.00237	CcSEcCtD
Trisalicylate-choline—Pain—Raloxifene—osteoporosis	0.000779	0.00235	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Zoledronate—osteoporosis	0.000774	0.00234	CcSEcCtD
Trisalicylate-choline—Constipation—Ibandronate—osteoporosis	0.000771	0.00233	CcSEcCtD
Trisalicylate-choline—Pain—Ibandronate—osteoporosis	0.000771	0.00233	CcSEcCtD
Trisalicylate-choline—Pruritus—Etidronic acid—osteoporosis	0.000769	0.00232	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Calcitriol—osteoporosis	0.000767	0.00232	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Alendronate—osteoporosis	0.000763	0.0023	CcSEcCtD
Trisalicylate-choline—Oedema—Ethinyl Estradiol—osteoporosis	0.000762	0.0023	CcSEcCtD
Trisalicylate-choline—Erythema—Conjugated Estrogens—osteoporosis	0.000761	0.0023	CcSEcCtD
Trisalicylate-choline—Pain—Calcitriol—osteoporosis	0.000755	0.00228	CcSEcCtD
Trisalicylate-choline—Constipation—Calcitriol—osteoporosis	0.000755	0.00228	CcSEcCtD
Trisalicylate-choline—Urticaria—Estropipate—osteoporosis	0.000747	0.00226	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000745	0.00225	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Etidronic acid—osteoporosis	0.000743	0.00225	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Ibandronate—osteoporosis	0.000743	0.00224	CcSEcCtD
Trisalicylate-choline—Urticaria—Alendronate—osteoporosis	0.000736	0.00222	CcSEcCtD
Trisalicylate-choline—Epistaxis—Estradiol—osteoporosis	0.000735	0.00222	CcSEcCtD
Trisalicylate-choline—Shock—Risedronate—osteoporosis	0.000731	0.00221	CcSEcCtD
Trisalicylate-choline—Urticaria—Ibandronate—osteoporosis	0.000716	0.00216	CcSEcCtD
Trisalicylate-choline—Confusional state—Pamidronate—osteoporosis	0.000712	0.00215	CcSEcCtD
Trisalicylate-choline—Oedema—Pamidronate—osteoporosis	0.000706	0.00213	CcSEcCtD
Trisalicylate-choline—Urticaria—Calcitriol—osteoporosis	0.000701	0.00212	CcSEcCtD
Trisalicylate-choline—Hepatitis—Estradiol—osteoporosis	0.0007	0.00211	CcSEcCtD
Trisalicylate-choline—Shock—Pamidronate—osteoporosis	0.000695	0.0021	CcSEcCtD
Trisalicylate-choline—Vomiting—Etidronic acid—osteoporosis	0.000691	0.00209	CcSEcCtD
Trisalicylate-choline—Rash—Etidronic acid—osteoporosis	0.000685	0.00207	CcSEcCtD
Trisalicylate-choline—Dermatitis—Etidronic acid—osteoporosis	0.000684	0.00207	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Pamidronate—osteoporosis	0.000683	0.00206	CcSEcCtD
Trisalicylate-choline—Headache—Etidronic acid—osteoporosis	0.000681	0.00206	CcSEcCtD
Trisalicylate-choline—Anorexia—Pamidronate—osteoporosis	0.000673	0.00203	CcSEcCtD
Trisalicylate-choline—Pruritus—Estropipate—osteoporosis	0.000665	0.00201	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Estradiol—osteoporosis	0.000662	0.002	CcSEcCtD
Trisalicylate-choline—Hypotension—Pamidronate—osteoporosis	0.00066	0.00199	CcSEcCtD
Trisalicylate-choline—Pruritus—Alendronate—osteoporosis	0.000655	0.00198	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Risedronate—osteoporosis	0.000654	0.00197	CcSEcCtD
Trisalicylate-choline—Tinnitus—Estradiol—osteoporosis	0.000652	0.00197	CcSEcCtD
Trisalicylate-choline—Constipation—Ethinyl Estradiol—osteoporosis	0.000652	0.00197	CcSEcCtD
Trisalicylate-choline—Confusional state—Zoledronate—osteoporosis	0.00065	0.00196	CcSEcCtD
Trisalicylate-choline—Flushing—Estradiol—osteoporosis	0.000649	0.00196	CcSEcCtD
Trisalicylate-choline—Nausea—Etidronic acid—osteoporosis	0.000645	0.00195	CcSEcCtD
Trisalicylate-choline—Oedema—Zoledronate—osteoporosis	0.000645	0.00195	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Estropipate—osteoporosis	0.000643	0.00194	CcSEcCtD
Trisalicylate-choline—Pruritus—Ibandronate—osteoporosis	0.000638	0.00193	CcSEcCtD
Trisalicylate-choline—Constipation—Risedronate—osteoporosis	0.000635	0.00192	CcSEcCtD
Trisalicylate-choline—Pain—Risedronate—osteoporosis	0.000635	0.00192	CcSEcCtD
Trisalicylate-choline—Shock—Zoledronate—osteoporosis	0.000635	0.00192	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Alendronate—osteoporosis	0.000633	0.00191	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000628	0.0019	CcSEcCtD
Trisalicylate-choline—Somnolence—Pamidronate—osteoporosis	0.000628	0.0019	CcSEcCtD
Trisalicylate-choline—Pruritus—Calcitriol—osteoporosis	0.000624	0.00189	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Zoledronate—osteoporosis	0.000624	0.00188	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Raloxifene—osteoporosis	0.000623	0.00188	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Pamidronate—osteoporosis	0.000622	0.00188	CcSEcCtD
Trisalicylate-choline—Dizziness—Estropipate—osteoporosis	0.000622	0.00188	CcSEcCtD
Trisalicylate-choline—Oedema—Conjugated Estrogens—osteoporosis	0.000621	0.00188	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Ibandronate—osteoporosis	0.000617	0.00186	CcSEcCtD
Trisalicylate-choline—Anorexia—Zoledronate—osteoporosis	0.000615	0.00186	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Pamidronate—osteoporosis	0.000614	0.00185	CcSEcCtD
Trisalicylate-choline—Dizziness—Alendronate—osteoporosis	0.000612	0.00185	CcSEcCtD
Trisalicylate-choline—Shock—Conjugated Estrogens—osteoporosis	0.000611	0.00185	CcSEcCtD
Trisalicylate-choline—Erythema—Estradiol—osteoporosis	0.000609	0.00184	CcSEcCtD
Trisalicylate-choline—Urticaria—Ethinyl Estradiol—osteoporosis	0.000605	0.00183	CcSEcCtD
Trisalicylate-choline—Pain—Pamidronate—osteoporosis	0.000604	0.00182	CcSEcCtD
Trisalicylate-choline—Constipation—Pamidronate—osteoporosis	0.000604	0.00182	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Calcitriol—osteoporosis	0.000604	0.00182	CcSEcCtD
Trisalicylate-choline—Hypotension—Zoledronate—osteoporosis	0.000603	0.00182	CcSEcCtD
Trisalicylate-choline—Dizziness—Raloxifene—osteoporosis	0.000602	0.00182	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.0006	0.00181	CcSEcCtD
Trisalicylate-choline—Vomiting—Estropipate—osteoporosis	0.000598	0.00181	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Estradiol—osteoporosis	0.000596	0.0018	CcSEcCtD
Trisalicylate-choline—Dizziness—Ibandronate—osteoporosis	0.000596	0.0018	CcSEcCtD
Trisalicylate-choline—Rash—Estropipate—osteoporosis	0.000593	0.00179	CcSEcCtD
Trisalicylate-choline—Dermatitis—Estropipate—osteoporosis	0.000592	0.00179	CcSEcCtD
Trisalicylate-choline—Anorexia—Conjugated Estrogens—osteoporosis	0.000592	0.00179	CcSEcCtD
Trisalicylate-choline—Urticaria—Risedronate—osteoporosis	0.00059	0.00178	CcSEcCtD
Trisalicylate-choline—Headache—Estropipate—osteoporosis	0.000589	0.00178	CcSEcCtD
Trisalicylate-choline—Vomiting—Alendronate—osteoporosis	0.000589	0.00178	CcSEcCtD
Trisalicylate-choline—Rash—Alendronate—osteoporosis	0.000584	0.00176	CcSEcCtD
Trisalicylate-choline—Dermatitis—Alendronate—osteoporosis	0.000583	0.00176	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Pamidronate—osteoporosis	0.000582	0.00176	CcSEcCtD
Trisalicylate-choline—Hypotension—Conjugated Estrogens—osteoporosis	0.00058	0.00175	CcSEcCtD
Trisalicylate-choline—Headache—Alendronate—osteoporosis	0.00058	0.00175	CcSEcCtD
Trisalicylate-choline—Vomiting—Raloxifene—osteoporosis	0.000579	0.00175	CcSEcCtD
Trisalicylate-choline—Rash—Raloxifene—osteoporosis	0.000574	0.00173	CcSEcCtD
Trisalicylate-choline—Dermatitis—Raloxifene—osteoporosis	0.000574	0.00173	CcSEcCtD
Trisalicylate-choline—Somnolence—Zoledronate—osteoporosis	0.000573	0.00173	CcSEcCtD
Trisalicylate-choline—Vomiting—Ibandronate—osteoporosis	0.000573	0.00173	CcSEcCtD
Trisalicylate-choline—Headache—Raloxifene—osteoporosis	0.00057	0.00172	CcSEcCtD
Trisalicylate-choline—Rash—Ibandronate—osteoporosis	0.000568	0.00172	CcSEcCtD
Trisalicylate-choline—Dermatitis—Ibandronate—osteoporosis	0.000568	0.00171	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Zoledronate—osteoporosis	0.000568	0.00171	CcSEcCtD
Trisalicylate-choline—Headache—Ibandronate—osteoporosis	0.000565	0.00171	CcSEcCtD
Trisalicylate-choline—Vomiting—Calcitriol—osteoporosis	0.000561	0.00169	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Zoledronate—osteoporosis	0.000561	0.00169	CcSEcCtD
Trisalicylate-choline—Nausea—Estropipate—osteoporosis	0.000558	0.00169	CcSEcCtD
Trisalicylate-choline—Rash—Calcitriol—osteoporosis	0.000556	0.00168	CcSEcCtD
Trisalicylate-choline—Dermatitis—Calcitriol—osteoporosis	0.000556	0.00168	CcSEcCtD
Trisalicylate-choline—Headache—Calcitriol—osteoporosis	0.000553	0.00167	CcSEcCtD
Trisalicylate-choline—Somnolence—Conjugated Estrogens—osteoporosis	0.000552	0.00167	CcSEcCtD
Trisalicylate-choline—Constipation—Zoledronate—osteoporosis	0.000552	0.00167	CcSEcCtD
Trisalicylate-choline—Pain—Zoledronate—osteoporosis	0.000552	0.00167	CcSEcCtD
Trisalicylate-choline—Nausea—Alendronate—osteoporosis	0.00055	0.00166	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000547	0.00165	CcSEcCtD
Trisalicylate-choline—Nausea—Raloxifene—osteoporosis	0.000541	0.00163	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00054	0.00163	CcSEcCtD
Trisalicylate-choline—Pruritus—Ethinyl Estradiol—osteoporosis	0.000539	0.00163	CcSEcCtD
Trisalicylate-choline—Nausea—Ibandronate—osteoporosis	0.000535	0.00162	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Zoledronate—osteoporosis	0.000532	0.00161	CcSEcCtD
Trisalicylate-choline—Constipation—Conjugated Estrogens—osteoporosis	0.000531	0.0016	CcSEcCtD
Trisalicylate-choline—Pain—Conjugated Estrogens—osteoporosis	0.000531	0.0016	CcSEcCtD
Trisalicylate-choline—Pruritus—Risedronate—osteoporosis	0.000526	0.00159	CcSEcCtD
Trisalicylate-choline—Nausea—Calcitriol—osteoporosis	0.000524	0.00158	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000521	0.00157	CcSEcCtD
Trisalicylate-choline—Urticaria—Zoledronate—osteoporosis	0.000512	0.00155	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Risedronate—osteoporosis	0.000508	0.00154	CcSEcCtD
Trisalicylate-choline—Dizziness—Ethinyl Estradiol—osteoporosis	0.000504	0.00152	CcSEcCtD
Trisalicylate-choline—Confusional state—Estradiol—osteoporosis	0.000501	0.00151	CcSEcCtD
Trisalicylate-choline—Pruritus—Pamidronate—osteoporosis	0.0005	0.00151	CcSEcCtD
Trisalicylate-choline—Oedema—Estradiol—osteoporosis	0.000497	0.0015	CcSEcCtD
Trisalicylate-choline—Urticaria—Conjugated Estrogens—osteoporosis	0.000493	0.00149	CcSEcCtD
Trisalicylate-choline—Dizziness—Risedronate—osteoporosis	0.000491	0.00148	CcSEcCtD
Trisalicylate-choline—Shock—Estradiol—osteoporosis	0.000489	0.00148	CcSEcCtD
Trisalicylate-choline—Vomiting—Ethinyl Estradiol—osteoporosis	0.000484	0.00146	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Pamidronate—osteoporosis	0.000483	0.00146	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Estradiol—osteoporosis	0.000481	0.00145	CcSEcCtD
Trisalicylate-choline—Rash—Ethinyl Estradiol—osteoporosis	0.00048	0.00145	CcSEcCtD
Trisalicylate-choline—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00048	0.00145	CcSEcCtD
Trisalicylate-choline—Headache—Ethinyl Estradiol—osteoporosis	0.000477	0.00144	CcSEcCtD
Trisalicylate-choline—Vomiting—Risedronate—osteoporosis	0.000472	0.00143	CcSEcCtD
Trisalicylate-choline—Rash—Risedronate—osteoporosis	0.000468	0.00141	CcSEcCtD
Trisalicylate-choline—Dermatitis—Risedronate—osteoporosis	0.000468	0.00141	CcSEcCtD
Trisalicylate-choline—Dizziness—Pamidronate—osteoporosis	0.000467	0.00141	CcSEcCtD
Trisalicylate-choline—Headache—Risedronate—osteoporosis	0.000465	0.00141	CcSEcCtD
Trisalicylate-choline—Pruritus—Zoledronate—osteoporosis	0.000456	0.00138	CcSEcCtD
Trisalicylate-choline—Nausea—Ethinyl Estradiol—osteoporosis	0.000453	0.00137	CcSEcCtD
Trisalicylate-choline—Vomiting—Pamidronate—osteoporosis	0.000449	0.00136	CcSEcCtD
Trisalicylate-choline—Rash—Pamidronate—osteoporosis	0.000445	0.00134	CcSEcCtD
Trisalicylate-choline—Dermatitis—Pamidronate—osteoporosis	0.000445	0.00134	CcSEcCtD
Trisalicylate-choline—Headache—Pamidronate—osteoporosis	0.000442	0.00134	CcSEcCtD
Trisalicylate-choline—Somnolence—Estradiol—osteoporosis	0.000442	0.00133	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Zoledronate—osteoporosis	0.000441	0.00133	CcSEcCtD
Trisalicylate-choline—Nausea—Risedronate—osteoporosis	0.000441	0.00133	CcSEcCtD
Trisalicylate-choline—Pruritus—Conjugated Estrogens—osteoporosis	0.000439	0.00133	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Estradiol—osteoporosis	0.000438	0.00132	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Estradiol—osteoporosis	0.000432	0.00131	CcSEcCtD
Trisalicylate-choline—Dizziness—Zoledronate—osteoporosis	0.000427	0.00129	CcSEcCtD
Trisalicylate-choline—Pain—Estradiol—osteoporosis	0.000425	0.00128	CcSEcCtD
Trisalicylate-choline—Constipation—Estradiol—osteoporosis	0.000425	0.00128	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000425	0.00128	CcSEcCtD
Trisalicylate-choline—Nausea—Pamidronate—osteoporosis	0.000419	0.00127	CcSEcCtD
Trisalicylate-choline—Dizziness—Conjugated Estrogens—osteoporosis	0.000411	0.00124	CcSEcCtD
Trisalicylate-choline—Vomiting—Zoledronate—osteoporosis	0.00041	0.00124	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Estradiol—osteoporosis	0.00041	0.00124	CcSEcCtD
Trisalicylate-choline—Rash—Zoledronate—osteoporosis	0.000407	0.00123	CcSEcCtD
Trisalicylate-choline—Dermatitis—Zoledronate—osteoporosis	0.000406	0.00123	CcSEcCtD
Trisalicylate-choline—Headache—Zoledronate—osteoporosis	0.000404	0.00122	CcSEcCtD
Trisalicylate-choline—Vomiting—Conjugated Estrogens—osteoporosis	0.000395	0.00119	CcSEcCtD
Trisalicylate-choline—Urticaria—Estradiol—osteoporosis	0.000395	0.00119	CcSEcCtD
Trisalicylate-choline—Rash—Conjugated Estrogens—osteoporosis	0.000392	0.00118	CcSEcCtD
Trisalicylate-choline—Dermatitis—Conjugated Estrogens—osteoporosis	0.000391	0.00118	CcSEcCtD
Trisalicylate-choline—Headache—Conjugated Estrogens—osteoporosis	0.000389	0.00118	CcSEcCtD
Trisalicylate-choline—Nausea—Zoledronate—osteoporosis	0.000383	0.00116	CcSEcCtD
Trisalicylate-choline—Nausea—Conjugated Estrogens—osteoporosis	0.000369	0.00111	CcSEcCtD
Trisalicylate-choline—Pruritus—Estradiol—osteoporosis	0.000352	0.00106	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Estradiol—osteoporosis	0.00034	0.00103	CcSEcCtD
Trisalicylate-choline—Dizziness—Estradiol—osteoporosis	0.000329	0.000993	CcSEcCtD
Trisalicylate-choline—Vomiting—Estradiol—osteoporosis	0.000316	0.000955	CcSEcCtD
Trisalicylate-choline—Rash—Estradiol—osteoporosis	0.000313	0.000947	CcSEcCtD
Trisalicylate-choline—Dermatitis—Estradiol—osteoporosis	0.000313	0.000946	CcSEcCtD
Trisalicylate-choline—Headache—Estradiol—osteoporosis	0.000311	0.000941	CcSEcCtD
Trisalicylate-choline—Nausea—Estradiol—osteoporosis	0.000295	0.000892	CcSEcCtD
Trisalicylate-choline—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—osteoporosis	0.000206	0.0742	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000191	0.069	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000152	0.0548	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000117	0.0421	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	0.000108	0.039	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	9.25e-05	0.0334	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	7.78e-05	0.0281	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	6.99e-05	0.0252	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	5.5e-05	0.0199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	4.86e-05	0.0175	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	4.75e-05	0.0171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	4.41e-05	0.0159	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP27A1—osteoporosis	4.13e-05	0.0149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	4.11e-05	0.0149	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	4.09e-05	0.0148	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.09e-05	0.0148	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	3.77e-05	0.0136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	3.31e-05	0.0119	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	3.3e-05	0.0119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	3.25e-05	0.0117	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	3.17e-05	0.0114	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	3.02e-05	0.0109	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	2.79e-05	0.0101	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.76e-05	0.00997	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	2.62e-05	0.00947	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.62e-05	0.00946	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	2.51e-05	0.00908	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.46e-05	0.00887	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.45e-05	0.00885	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	2.4e-05	0.00866	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	2.23e-05	0.00806	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	2.21e-05	0.00799	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.19e-05	0.00792	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP19A1—osteoporosis	2.17e-05	0.00784	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.08e-05	0.00751	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.04e-05	0.00735	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.98e-05	0.00717	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.75e-05	0.0063	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.72e-05	0.00621	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	1.65e-05	0.00597	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—LEP—osteoporosis	1.63e-05	0.00588	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.62e-05	0.00584	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.6e-05	0.00578	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.59e-05	0.00573	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.58e-05	0.00569	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	1.5e-05	0.00541	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.35e-05	0.00487	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	1.31e-05	0.00474	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—POMC—osteoporosis	1.3e-05	0.00471	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.26e-05	0.00455	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PKM—osteoporosis	1.23e-05	0.00444	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FDPS—osteoporosis	1.23e-05	0.00444	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	1.2e-05	0.00434	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PGLS—osteoporosis	1.17e-05	0.00421	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPD2—osteoporosis	1.17e-05	0.00421	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SOST—osteoporosis	1.17e-05	0.00421	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PKM—osteoporosis	1.17e-05	0.00421	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PGLS—osteoporosis	1.11e-05	0.00399	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ANTXR2—osteoporosis	1.11e-05	0.00399	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.07e-05	0.00387	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ATIC—osteoporosis	1.07e-05	0.00385	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PNP—osteoporosis	1.07e-05	0.00385	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	1.06e-05	0.00383	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.06e-05	0.00382	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	1.04e-05	0.00375	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PKM—osteoporosis	9.77e-06	0.00353	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FDPS—osteoporosis	9.77e-06	0.00353	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	9.69e-06	0.0035	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	9.53e-06	0.00344	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GSN—osteoporosis	9.4e-06	0.00339	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPD2—osteoporosis	9.26e-06	0.00334	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PGLS—osteoporosis	9.26e-06	0.00334	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	9.16e-06	0.00331	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—OXCT1—osteoporosis	9.07e-06	0.00327	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA2—osteoporosis	9.07e-06	0.00327	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MGLL—osteoporosis	8.84e-06	0.00319	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ATIC—osteoporosis	8.47e-06	0.00306	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PNP—osteoporosis	8.47e-06	0.00306	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.34e-06	0.00301	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LRP5—osteoporosis	8.18e-06	0.00295	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MYC—osteoporosis	8.09e-06	0.00292	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	8.07e-06	0.00291	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LRP6—osteoporosis	7.82e-06	0.00282	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	7.69e-06	0.00278	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—osteoporosis	7.54e-06	0.00272	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—IDH2—osteoporosis	7.52e-06	0.00271	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPL24—osteoporosis	7.52e-06	0.00271	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LTF—osteoporosis	7.52e-06	0.00271	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—OXCT1—osteoporosis	7.2e-06	0.0026	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA2—osteoporosis	7.2e-06	0.0026	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP27A1—osteoporosis	7.07e-06	0.00255	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MGLL—osteoporosis	7.02e-06	0.00253	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACP5—osteoporosis	6.87e-06	0.00248	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.79e-06	0.00245	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.62e-06	0.00239	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ACP5—osteoporosis	6.52e-06	0.00235	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TPI1—osteoporosis	6.39e-06	0.00231	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—osteoporosis	6.08e-06	0.0022	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TPI1—osteoporosis	6.06e-06	0.00219	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—P4HB—osteoporosis	6.01e-06	0.00217	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—IDH2—osteoporosis	5.97e-06	0.00215	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GAPDH—osteoporosis	5.9e-06	0.00213	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—RAP1A—osteoporosis	5.74e-06	0.00207	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—P4HB—osteoporosis	5.7e-06	0.00206	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP27A1—osteoporosis	5.61e-06	0.00203	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GAPDH—osteoporosis	5.59e-06	0.00202	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.5e-06	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.49e-06	0.00198	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACP5—osteoporosis	5.46e-06	0.00197	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.39e-06	0.00195	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NFATC1—osteoporosis	5.31e-06	0.00192	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—DKK1—osteoporosis	5.27e-06	0.0019	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.13e-06	0.00185	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—WNT1—osteoporosis	5.08e-06	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TPI1—osteoporosis	5.07e-06	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.01e-06	0.00181	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGA—osteoporosis	4.94e-06	0.00178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—P4HB—osteoporosis	4.77e-06	0.00172	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GAPDH—osteoporosis	4.68e-06	0.00169	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ENO1—osteoporosis	4.64e-06	0.00168	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PSMA5—osteoporosis	4.58e-06	0.00165	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PSMA2—osteoporosis	4.58e-06	0.00165	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—RAP1A—osteoporosis	4.56e-06	0.00165	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ENO1—osteoporosis	4.4e-06	0.00159	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PSMA2—osteoporosis	4.34e-06	0.00157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PSMA5—osteoporosis	4.34e-06	0.00157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CALCA—osteoporosis	4.04e-06	0.00146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.98e-06	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP19A1—osteoporosis	3.71e-06	0.00134	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ENO1—osteoporosis	3.69e-06	0.00133	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KL—osteoporosis	3.67e-06	0.00133	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PSMA2—osteoporosis	3.63e-06	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PSMA5—osteoporosis	3.63e-06	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ADCY5—osteoporosis	3.03e-06	0.0011	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPX1—osteoporosis	3.02e-06	0.00109	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP19A1—osteoporosis	2.95e-06	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ADCY5—osteoporosis	2.87e-06	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—osteoporosis	2.79e-06	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—osteoporosis	2.64e-06	0.000955	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS2—osteoporosis	2.52e-06	0.000908	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADCY5—osteoporosis	2.41e-06	0.000869	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPX1—osteoporosis	2.4e-06	0.000866	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—POMC—osteoporosis	2.23e-06	0.000805	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—osteoporosis	2.21e-06	0.0008	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS1—osteoporosis	2.2e-06	0.000793	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6R—osteoporosis	2.06e-06	0.000745	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—POMC—osteoporosis	1.77e-06	0.000639	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYC—osteoporosis	1.22e-06	0.000441	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—osteoporosis	1.22e-06	0.00044	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—osteoporosis	9.19e-07	0.000332	CbGpPWpGaD
